quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·15d
PRRelease
Context Therapeutics Inc. logo
Neogen Corporation logo

Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary

CNTX· Context Therapeutics Inc.NEOG· Neogen Corporation
Health Care
Original source

Companies

  • CNTX
    Context Therapeutics Inc.
    Health Care
  • NEOG
    Neogen Corporation
    Health Care

Recent analyst ratings

  • Sep 18CNTXUpdateGuggenheim$5.00
  • Jul 29NEOGUpdateWilliam Blair-
  • Apr 21CNTXUpdateWilliam Blair-
  • Jan 8CNTXUpdateJMP Securities$4.00
  • Dec 19NEOGUpdateGuggenheim$15.00
  • Nov 25CNTXUpdateD. Boral Capital$9.00

Related

  • PR15h
    Neogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification
  • SEC3d
    Neogen Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC6d
    SEC Form PRE 14A filed by Context Therapeutics Inc.
  • INSIDER10d
    SEC Form 3 filed by new insider Stacey Jennifer Evans
  • SEC14d
    SEC Form 10-Q filed by Neogen Corporation
  • SEC14d
    Neogen Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR14d
    Neogen Reports Third Quarter Fiscal Year 2026 Financial Results
  • SEC21d
    Context Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022